INAB (STOCKS)
IN8bio, Inc. Common Stock
$1.390000
-0.040000 (-2.80%)
Prev close: $1.430000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- William T. Ho
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13.69M
- Employees
- 18
- P/E (TTM)
- -0.49
- P/B (TTM)
- 0.62
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.26 | $-0.70 | +0.4438 | +63.06% |
|
Dec 2025 (Q4)
|
$-0.45 | $-0.63 | +0.1790 | +28.46% |
|
Sep 2025 (Q3)
|
$-0.85 | $-1.25 | +0.4046 | +32.25% |
|
Jun 2025 (Q2)
|
$-1.24 | $-1.84 | +0.5960 | +32.46% |
Financial Statements
| Revenues | $487.00K |
| Benefits Costs and Expenses | $19.47M |
| Costs And Expenses | $19.47M |
| Operating Expenses | $19.47M |
| Research and Development | $9.85M |
| Other Operating Expenses | $9.62M |
| Operating Income/Loss | -$18.98M |
| Income/Loss From Continuing Operations After Tax | -$16.56M |
| Income/Loss From Continuing Operations Before Tax | -$18.98M |
| Net Income/Loss | -$18.98M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$18.98M |
| Net Income/Loss Available To Common Stockholders, Basic | -$18.98M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.61 |
| Diluted Earnings Per Share | -$2.61 |
| Basic Average Shares | 29,033,021 |
| Diluted Average Shares | 29,033,021 |
| Assets | $26.27M |
| Current Assets | $22.66M |
| Noncurrent Assets | $3.60M |
| Fixed Assets | $1.62M |
| Other Non-current Assets | $1.98M |
| Liabilities | $3.48M |
| Current Liabilities | $2.16M |
| Accounts Payable | $449.00K |
| Other Current Liabilities | $1.71M |
| Noncurrent Liabilities | $1.33M |
| Equity | $22.78M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $22.78M |
| Liabilities And Equity | $26.27M |
| Net Cash Flow From Operating Activities | -$14.54M |
| Net Cash Flow From Operating Activities, Continuing | -$14.54M |
| Net Cash Flow From Investing Activities | -$15.16M |
| Net Cash Flow From Investing Activities, Continuing | -$15.16M |
| Net Cash Flow From Financing Activities | $24.55M |
| Net Cash Flow From Financing Activities, Continuing | $24.55M |
| Net Cash Flow | -$5.15M |
| Net Cash Flow, Continuing | -$5.15M |
| Comprehensive Income/Loss | -$18.98M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$18.98M |
| Other Comprehensive Income/Loss | $0.00 |